SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Setara Biosciences Announces $90 Million Series A Financing

Setara Biosciences announced a $90 million Series A financing to advance precision medicines for rare genetic diseases and related expansion indications. The company was created following Jazz Pharmaceuticals’ acquisition of Actio Biosciences.

Related stories